Pictet Asset Management Sa Global Blood Therapeutics, Inc. Transaction History

Pictet Asset Management Sa

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $260,269 - $547,689	8,033 Added 8.72%	100,199 $6.82 Million
Q2 2022 Aug 09, 2022	BUY	$22.3 - $37.39 $926,966 - $1.55 Million	41,568 Added 82.15%	92,166 $2.95 Million
Q4 2021 Feb 10, 2022	BUY	$24.9 - $40.26 $1.26 Million - $2.04 Million	50,598 New	50,598 $1.48 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.